Central chondrosarcoma progression is associated with pRb pathway alterations: CDK4 down-regulation and p16 overexpression inhibit cell growth in vitro-Reference-Cited by-同舟云学术

Central chondrosarcoma progression is associated with pRb pathway alterations: CDK4 down-regulation and p16 overexpression inhibit cell growth in vitro

Published:2009-09 Issue:9a Volume:13 Page:2843-2852
ISSN:1582-1838
Container-title:Journal of Cellular and Molecular Medicine
language:en
Short-container-title:

Author:

Schrage Yvonne M.,Lam Suzanne,Jochemsen Aart G.,Cleton-Jansen Anne-Marie,Taminiau Antonie H.M.,Hogendoorn Pancras C.W.,Bovée Judith V.M.G.

Publisher

Wiley

Subject

Cell Biology,Molecular Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1582-4934.2008.00406.x/fullpdf

Reference38 articles.

1. Prognostic factors in chondrosarcoma of bone. A clinicopathologic analysis with emphasis on histologic grading;Evans;Cancer.,1977

2. Benign and malignant cartilage tumors of bone and joint: their anatomic and theoretical basis with an emphasis on radiology, pathology and clinical biology I. The intramedullary cartilage tumors;Brien;Skeletal Radiol.,1997

3. Loss of heterozygosity and tumor suppressor gene mutations in chondrosarcomas;Yamaguchi;Anticancer Res.,1996

Cited by 81 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular Developments in Parasellar Tumors and Potential Therapeutic Implications;Endocrine Reviews;2024-07-26

2. A Systematic Review of Adjuvant Chemotherapy in Localized Dedifferentiated Chondrosarcoma;Current Oncology;2024-01-19

3. IDH Mutations in Chondrosarcoma: Case Closed or Not?;Cancers;2023-07-13

4. Bad to the Bone: Emerging Approaches to Aggressive Bone Sarcomas;American Society of Clinical Oncology Educational Book;2023-05

5. Multidrug resistance protein 1 silencing in osteosarcoma and chondrosarcoma cell lines;Journal of Cancer Research and Therapeutics;2023